Latham, Shearman Assist in Amgen’s $4.5 Billion Financing

McDermott was noted as providing antitrust counsel to Amgen, Inc. for the company’s 2013 acquisition of San Francisco-based Onyx Pharmaceuticals, a $9.7 billion transaction that was the biotech firm’s largest M&A deal ever.